Abstract:Background: Colorectal cancers (CRC) show high morbidity and mortality. Especially, the consensus molecular subtypes 4 (CMS4)-CRC shows extremely poor prognosis and high chemo-resistance rate, in compared with the other types of CRC. CMS4-CRC is histologically characteristic for the extensive stromal infiltration with poorly differentiated cancer cells in the tumor microenvironment. Several studies have reported that sessile serrated adenomas, which is characterized by disorganized crypt architecture and irregular serrations with high malignant potential such as epithelial-mesenchymal transition and TGFβ signaling, might be closely associated with CMS4-CRC. Fascin-1 is an actin-binding protein supposed to be associated with sessile serrated adenomas. However, the expression and clinical significance of fascin-1 in CMS4 CRC remains to be unclear. Aim: The aim of this study was to clarify the clinic-pathological significance of fascin-1 in colorectal cancer, and to evaluate the effects of fascin-1 inhibitors on the invasion and migration ability of CMS4 cancer cell lines. Materials and Methods: We conducted an immunohistochemical study on 351 colorectal cancer patients, where we examined the expression levels of Fascin-1 and analyzed their correlation with the patients' clinicopathologic features. Using two human CMS4-CRC cell lines, SW480 and HCT116, we investigated the effects of the fascin-1 inhibitors, NP-G2-044 and BDP-13176, on the proliferation and the migration activity of CMS4-CRC cells via MTT assay and a wound-healing assay. Results: Fascin-1 is expressed both on cancer cells and on stromal cells, but mainly expressed on cancer cells. Significance of fascin-1 expression on cancer cells was evaluated in this study. Fascin-1 expression is significantly associated with histologically poorly differentiation (p < 0.001), deeper T invasion (p = 0.003), and proximal colon cancer (p < 0.001). High fascin-1 expression is significantly associated with worse prognosis (p = 0.0085, log-rank) and higher recurrence rates (p = 0.018). Univariate analysis demonstrated that overall survival of patients was significantly associated with Fascin1 expression in cancer cells, age ≥65 years old, poor histological type, lymphatic invasion, lymph node metastasis, and venous invasion. Multivariate analysis revealed that fascin1 expression (p = 0.037), poor histological type (p = 0.022), venous invasion (p = 0.078), and lymph node metastasis (p = 0.009) were significantly correlated with the overall survival rate of CRC patients. Both fascin-1 inhibitors significantly reduced the invasion and migration of colorectal cancer cells at the concentration of 100 nM. Conclusions: Fascin-1 is one of key molecules for the development of CRC. Fascin-1 might be a promising molecular target for CMS4-CRC patients at advanced stage. Citation Format: Canfeng Fan, Qiang Wang, Rika Aoyama, Hinano Nishikubo, Kyouka Kawabata, Imanishi Daiki, Takashi Sakuma, Koji Maruo, Gen Tsujio, Yurie Yamamoto, Tatsunari Fukuoka, Masakazu Yashiro. Fascin1 might be a promising molecular target for colorectal cancer patients at advanced stage [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7587.

Involvement of CYR61 and CTGF in the Fascin-Mediated Proliferation and Invasiveness of Esophageal Squamous Cell Carcinomas Cells.

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

Fas Signaling Promotes Gastric Cancer Metastasis Through STAT3-Dependent Upregulation of Fascin.

Expression of Fascin in Esophageal Squamous Cell Carcinoma by Tissue Array Analysis

KAT8/SIRT7‐mediated Fascin‐K41 acetylation/deacetylation regulates tumor metastasis in esophageal squamous cell carcinoma

Expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance ? a tissue microarray study of 129 cases

Abstract 7587: Fascin1 might be a promising molecular target for colorectal cancer patients at advanced stage

P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer

Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes

Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis

LAMC1 upregulation via TGFβ induces inflammatory cancer‐associated fibroblasts in esophageal squamous cell carcinoma via NF‐κB–CXCL1–STAT3

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway

Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling

Tissue Microarray Analysis Reveals a Tight Correlation Between Protein Expression Pattern and Progression of Esophageal Squamous Cell Carcinoma

Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma

Fascin Inhibitor NP-G2-044 Decreases Cell Metastasis and Increases Overall Survival of Mice-Bearing Lung Cancers

FUT6 Suppresses the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Esophageal Carcinoma Cells via the Epidermal Growth Factor Receptor/Extracellular Signal-Regulated Kinase Signaling Pathway

circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR‐155‐5p/FZD5 axis

Abstract 3612: KAT8/SIRT7-medicated fascin-K41 acetylation/deacetylation regulates tumor metastasis

Circ_ZNF778_006 promoted ESCC progression by upregulating HIF-1α expression via sponging miR-18b-5p